Introduction
Various adaptive immune cells including T lymphocytes play a crucial role in modulating atherogenesis, plaque progression, and vascular dysfunction. 1, 2 During the induction of an adaptive immune response, T cells need to recognize their cognate antigen via their specific T cell antigen receptor (TCR) and receive proper co-stimulation for their activation, proliferation, survival, and effector differentiation. 3 Recent studies revealed that ablation of either CD28 or its ligands CD80 or CD86 ameliorates atherogenesis and promotes stable plaques. 4 The co-stimulatory axis CD40/CD154 (CD40L) exerts many different effects and is involved in B cell help to switch the antibody isotype and in cell activation including cytokine release. 5 Deficiency in either CD40 or CD154 leads to a profound reduction in atherosclerotic plaque burden. 6, 7 The co-stimulatory receptor CD27 and its ligand CD70 are members of the tumour necrosis factor (TNF) receptor and ligand family. Both play decisive roles in establishing T cell responses and memory. [8] [9] [10] CD27 is expressed on naïve T cells at steady state while it is also found on natural killer (NK) cells, activated B cells, and haematopoietic stem cells in mice. CD70 is transiently expressed on activated T cells, B cells, and dendritic cells (DC) thus reflecting recent antigenic stimulation. However, medullary thymic epithelial cells (mTEC) and radio-resistant antigen presenting cells (APC) in the lamina propria express CD70 constitutively. 11, 12 The exclusive expression pattern of CD27 and CD70 suggests important roles of these molecules during the initiation of a T cell response not only at the priming site, but also in non-lymphoid tissue.
The thymic development of conventional CD4 þ and CD8 þ T cells appears independent of CD27 under steady-state conditions. 8 Nonetheless, a recent study indicates that interactions between CD27 on developing T cells and CD70 on mTEC and DCs in the thymic medulla decreases apoptosis and promotes the development of natural (n) regulatory T cells (Treg). 12 Upon acute immune activation, such as infection, CD27/CD70 costimulation stimulates clonal expansion of antigen-specific T cells and is required to establish T cell memory, amongst others by promoting survival of activated T cells. [13] [14] [15] [16] [17] Furthermore, CD27/CD70 co-stimulation facilitates the survival of effector T cells in non-lymphoid tissues by stimulating their autocrine interleukin (IL)-2 production. 16 
Different CD4
þ T cell subsets play decisive roles in atherosclerosis progression. Indeed, Th1 cells and their key cytokines including interferon gamma (IFNc) drive inflammation and atherosclerosis while the role of Th17 cells and their hallmark cytokine IL-17 remains controversial. 18, 19 CD4 þ Tregs dampen effector T cell responses thus controlling pro-inflammatory action and protecting against atherosclerosis. Of note, patients suffering from acute coronary syndromes harbour reduced numbers and suppressive activity of circulating Tregs as compared with controls. [20] [21] [22] [23] In hyperlipidaemic mice, the transfer of Tregs 4 or the induction of a Treg response 24 ameliorated atherosclerosis, whereas the depletion of Tregs aggravated disease. 25 Considering the eminent role of T cells in atherosclerosis and the versatile contribution of CD27 signalling in modulating the function of conventional and regulatory T cells, we examined the effect of CD27 deficiency on early and advanced stages of atherosclerosis in two different mouse models of atherosclerosis. 
Methods

Cd27
Results
CD27 co-localizes with T lymphocytes and associates with ruptured human atherosclerotic lesions
Human carotid atherosclerotic plaques, histologically classified as ruptured, display a higher CD27 expression compared to stable carotid atherosclerotic plaques ( Figure 1A) . CD27 is almost exclusively expressed on CD3 þ T cells in human atherosclerotic lesions Bone marrow-derived CD27 deficiency increases atherosclerosis and promotes a pro-inflammatory plaque phenotype Figure 2E ). Immunohistochemical analysis of the aortic sinus suggested less CD4 þ T cells in bone marrow chimeric mice lacking CD27 ( Figure   2F ). Interestingly, the deficiency of CD27 in bone marrow-derived cells led to a significant decrease in lesional Treg numbers accompanied by an increased macrophage content assayed by staining for Foxp3 and CD68, respectively ( Figure 2G and H). Figure S2A and B). These data suggest a pro-inflammatory plaque milieu with less anti-inflammatory Tregs present in the atherosclerotic lesion resulting in accelerated plaque progression.
Bone marrow-derived CD27 deficiency decreases systemic Treg abundance and promotes vascular inflammation 
Apoe
-/-bone marrow revealed a significant increase in pro-inflammatory genes. The Th2-associated marker Gata-3 was significantly increased in the aorta, whereas Rorc (encoding Rorct) and
Foxp3 were only mildly reduced displaying a potential shifting of T cell subsets in the aorta compared with Cd27
-transplanted controls ( Figure 3F , see Supplementary material online, Figure S3) . Furthermore, the pro-inflammatory chemokine Ccl1 and the adhesion molecules Icam1 and Vcam1 were significantly increased potentially promoting leukocyte influx into the lesion, leading to macrophage accumulation and perpetuating atherosclerosis ( Figure 3F) . Indeed, CD27-deficient transplanted mice displayed a higher ICAM-1 staining on the plaque endothelium as demonstrated by immunohistochemistry (see Supplementary material online, Figure S2C ). In addition, the proinflammatory cytokines Il1b, Il6, and Il12p35 were significantly increased ( Figure 3F ). These data indicate the presence of a persistent inflammatory reaction in the arterial wall of Cd27 -/-Apoe -/-bone marrow chimeras likely due to reduced abundance of Tregs.
To investigate whether systemic reduction of Treg numbers also causes changes in plasma cytokine expression, multiplex-bead based assays and ELISA were applied. Since Tregs are a potent source for transforming growth factor beta (TGFb), decreased Treg numbers may account for systemically lower concentrations of this anti-inflammatory cytokine. Indeed, plasma TGFb was reduced ( Figure 3G ). The plasma abundance of other cytokines was not affected (see Supplementary material online, Figure S4 ).
CD27 deficiency increases nTreg apoptosis but does not affect their migratory or suppressive capacity
Reduced abundance of Tregs in lymphoid organs may be a consequence of reduced CCR7 expression leading to decreased sensitivity of Tregs to the lymph node-homing chemokines CCL19 and CCL21. Interestingly, CCL19 seemed not to affect Treg migration in transwell assays at any concentration (see Supplementary material online, Figure S5A ), however, caused total CD4 þ cell migration (data not shown). In contrast, CCL21 promoted migration of Treg although the migratory capacity was not different between genotypes (see Supplementary material online, Figure S5B ). Next, we addressed whether the mild pro-inflammatory and pro-atherosclerotic phenotype relates to an overall reduction of Treg frequency or whether the suppressive capacity per single Treg differs. Co-culture of CFSElabelled and anti-CD3/CD28-stimulated CD4 þ T cells with varying
show any difference in the fraction of divided conventional T cells indicating similar suppressive capacity between wild-type-and CD27-deficient Tregs ( Figure 4A and B). Recent studies demonstrated impaired Treg survival upon disruption of CD27 signalling 12, 27 prompting us to investigate whether Cd27 Figure 4D and E and see Supplementary material online, Figure S6 ). Moreover, splenic Tregs in the bone marrow transplantation model displayed significantly reduced Ki-67 staining indicating less proliferation of these cells ( Figure 3C and E). Thus, our observation of increased atherosclerosis in CD27-deficient mice may stem from overall limited numbers of Treg caused by reduced survival in the thymus and impaired proliferation in the periphery.
Systemic CD27 deficiency aggravates early atherogenesis, but does not affect advanced atherosclerosis
The transplantation of CD27-deficient bone marrow leads to leukocytosis which we can confirm in our model ( Table 1) . 28 Since leukocytosis promotes atherosclerosis, 29 we could not determine whether either leukocytosis or reduced Treg frequency are the underlying causes for exacerbated atherosclerosis. To exclude leukocytosis we applied a milder model of atherosclerosis without the need for bone marrow transplantation using Cd27 þ/þ Apoe -/-and Cd27 -/-Apoe -/-compound-mutant mice consuming a chow diet. Absolute and relative lesion area was increased in Cd27 -/-Apoe -/-mice compared with littermate controls at the age of 18 weeks (Figure 5A-C) In addition, increased macrophage content was observed corroborating the phenotype observed in the bone marrow chimeras ( Figure 5G ). CD3 þ T cells and CD4 þ T cells appeared less frequent in atherosclerotic lesions of CD27-deficient compared to littermate control mice ( Figure 5E and F) . Furthermore, the collagen content in atherosclerotic lesions did not change among groups while lesions seemed phenotypically more advanced in accordance with increased lesion size ( Figure 5D and H). Although at this early stage of plaque development no Tregs could be detected histologically, flow cytometry of splenic and aortic suspensions, lymph nodes, and blood ( Figure 6A-D Of note, aged 28-week-old Cd27 -/-mice and their controls did neither display alteration in absolute and relative plaque size ( Figure 7A-C) , nor did they differ in content of lesional CD3 þ T cells, CD4 þ T cells, Tregs, macrophages, or collagen ( Figure 7E-I) . In addition, the classification of atherosclerotic lesions of 28 week-old Cd27
Apoe -/-and Cd27 -/-Apoe -/-mice did not yield any relevant differences ( Figure 7D) . Concomitantly, flow cytometry demonstrated similar abundance of Tregs in spleen, lymph nodes, and in circulation between groups (see Supplementary material online, Figure S8A -C). Of note, CD27 deficiency did neither change body weight nor total plasma cholesterol or distribution among lipoprotein fractions ( Table 1 and see Supplementary material online, Figure S9A and B).
Discussion
Human atherosclerotic lesions harbour a substantial amount of T cells expressing CD27. Ruptured atherosclerotic lesions display increased expression of CD27 compared with stable lesions thereby implicating CD27 in this process. The present study indicates that in atherosclerosis CD27 co-stimulation increases Treg responses, which is associated with reduced disease symptoms. In a model of bone marrow transplantation, CD27 deficiency caused a substantial increase in atherosclerotic lesion size accompanied by less Tregs and more macrophages in these lesions. Moreover, the majority of plaques displayed an advanced phenotype. In addition, CD27-deficiency in bone marrow-derived cells promoted inflammation in atherosclerotic lesions as also demonstrated by increased expression of proinflammatory chemokines, cytokines, and adhesion molecules in the murine aorta. This pronounced inflammatory phenotype is likely evoked by a systemic decrease in Treg abundance. However, TGFb can suppress major histocompatibility complex II (MHCII) expression on APC, stimulate SMC proliferation, collagen synthesis, and decrease matrix metalloproteinase expression, thus stabilizing the collagen content and the phenotype of the atherosclerotic lesion. 36 A decrease in systemic levels of TGFb may be attributable to a systemic decrease of Tregs as the potential source and explain the increased pro-inflammatory status of CD27-deficient mice.
Since Tregs are in a balance with Th17 cells it is tempting to speculate that a decrease of Tregs could lead to a more pronounced Th17 response. Indeed, in a murine model of experimental autoimmune encephalomyelitis, CD27 signalling decreased Th17 function and disease severity by suppressing IL-17 production and CCR6 expression in already committed Th17 cells. 37 However, plasma levels of IL-17 and the expression of the lineagespecific marker Rorct in the aorta were unchanged in mice reconstituted with Cd27 bone marrow. Concomitantly, the expression of the IL-12p35 subunit increased suggesting increased abundance of IL-12 whereas expression of the IL-23p19 subunit tended to decrease in mice transplanted with CD27-deficient bone marrow. This argues for a shift towards a Th1 T cell response and a reduced Th17 response since IL-23 is needed for maintenance of Th17 cells. 38 Furthermore, the expression of GATA-3 is substantially increased. However, GATA-3 is expressed by Th2 T cells and M2 macrophages and origin here remains elusive. Although the abundance of aortic Treg was diminished in mice reconstituted with Cd27 -/-bone marrow we were only 
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Plasma cholesterol (mM) able to detect a trend in reduced expression of the lineage transcription factor Foxp3. This discrepancy may derive from the analysis of whole tissue lysates which contain cells not only from the plaque but also from additional layers of the vessel thus diluting the abundance of Foxp3 mRNA. IL-2 is an autocrine T cell survival factor important for Treg maintenance in the periphery. 39 Plasma IL-2 levels did not differ in Cd27
-/-recipient mice of the present study. However, systemic IL-2 levels require careful interpretation with regard to Treg prevalence since a recent study demonstrated a necessity of IL-2 in the micro-milieu for Treg maintenance. 40 Nonetheless, we propose that in the chronic inflammatory condition of atherosclerosis, reduced production of IL-2 by activated conventional Cd27 -/-T cells 16 A second pathway that most likely contributes to the lesional inflammation observed in CD27-deficient mice in our study is the systemic decrease in nTregs apparently stemming from increased apoptosis of developing nTregs in the thymus. Indeed, ligation of CD27 by CD70 expressed on mTECs or DC was found to promote the thymic output of nTregs during T cell development in wild-type mice. 12 However, the low though relevant abundance of Tregs in the atherosclerotic lesion makes it difficult to delineate whether they originate from converted conventional T cells or underwent thymic development. Thus, it is not clear which of the two aforementioned mechanisms prevails. Interestingly, patients suffering from non-ST-segment-elevated myocardial infarction harbor lower numbers of circulating Treg accompanied by enhanced apoptosis demonstrating the clinical potential of counterbalancing Treg apoptosis. 42 Tregs have a distinct kinetic in atherosclerosis as recently demonstrated. 43 Presence in atherosclerotic lesions peaked upon 4 weeks 43 compared with our present study requires cautious interpretation as different hyperlipidaemic mouse models were employed. To our knowledge, this is the first study demonstrating the involvement of CD27 in atherosclerosis ascribing this co-stimulatory molecule a rather anti-inflammatory and athero-protective role by enhancing Treg survival and development. However, a previous report suggested an anti-atherosclerotic effect by chronic expression of CD70 on B cells leading to continuous triggering of CD27 on T cells and an increase in the pro-atherogenic Th1 subset. 44 Surprisingly, CD70 overexpression exerts rather athero-protective effects which are probably due to an increased rate of apoptosis among the pro-atherogenic Ly6C þ monocytes, lack of which likely ameliorates atherosclerosis. Although pioneering in its approach this study employed a rather artificial, B cell-restricted overexpression which led to a severe patho-inflammatory phenotype. Indeed, these mice display a gradual loss of the naïve T cell pool and a profound reduction of B cells thus not allowing a precise assessment of the role of CD27 and CD70 in atherosclerosis. 44 Recently, we described CD70 expression in atheroma localizing to macrophages. 45 Furthermore, lack of CD70 both systemically and in bone marrow-derived cells led to accelerated atherosclerosis in hyperlipidaemic mice paralleling the findings of our current study. Abundance of Tregs was reduced in CD70-deficient mice albeit to a lesser extent than observed here in mice lacking CD27. 45 Notably, we also found that macrophage viability and function, in particular their effective phagocytosis and efflux of oxLDL, strongly depends on CD70. 45 These data indicate that both similar and distinct atheroprotective mechanisms operate on the respective CD27-and CD70-expressing cell types necessitating further studies to delineate the cell type-specificity and exclusiveness of CD27/CD70 interaction. In summary, our study demonstrates a role for CD27 in thymic development and systemic frequency of Treg, which limits plaque initiation and progression towards intermediate atherosclerosis.
Deficiency of CD27 promotes a pro-inflammatory state of the plaque and aorta whereas adoptive transfer of Tregs can reverse this increase in atherosclerosis in CD27-deficient mice. At later stages of experimental atherosclerosis, CD27-mediated effects, especially on Tregs, appear not relevant.
Supplementary material
Supplementary material is available at European Heart Journal online.
Translational perspective
Deficiency of CD27 impairs thymic output of regulatory T cells and exacerbates atherosclerosis. Thus, CD27 activity may mitigate plaque development and prevent cardiovascular complications of atherosclerosis. Since modulation of CD27 activity is currently in clinical development for treatment of patients suffering from melanoma and B-or T cell lymphoma, adverse effects on the cardiovascular system of these patients should be monitored carefully.
